Biogen BIIB
NASDAQ BIIB
$216.78 +2.43 (+1.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biogen (BIIB) Short term Debt (2012 - 2026)

Biogen (BIIB) posted quarterly Short term Debt of $800.0 million for Q2 2026, up 433.33% year-over-year from $150.0 million in Q2 2025, and up 433.33% quarter-over-quarter from $150.0 million in Q2 2025.

Biogen (BIIB) Short term Debt (2012 - 2026) Analysis & Trends

Biogen's Short term Debt history runs 13 years deep, the most recent figure standing at $800.0 million for Q2 2026.

  • In Q2 2026, Short term Debt rose 433.33% year-over-year to $800.0 million; the TTM figure through Jun 2026 stood at $800.0 million (up 433.33% YoY), while the FY2024 annual figure was $1.7 billion, up 1065.73% from the prior year.
  • Short term Debt for Q2 2026 stood at $800.0 million, up from $150.0 million in the prior quarter.
  • The five-year high for Short term Debt was $1.7 billion in Q4 2024, with the low at $150.0 million in Q4 2023.
  • The 4-year median for Short term Debt is $475.0 million (2023), against an average of $712.2 million.
  • The sharpest annual moves came in 2024 and 2026: Short term Debt surged 1065.73% in 2024, then surged 433.33% in 2026.
  • Biogen's Short term Debt stood at $150.0 million in 2023, then soared by 1065.73% to $1.7 billion in 2024, then tumbled by 91.42% to $150.0 million in 2025, then soared by 433.33% to $800.0 million in 2026.
  • Business Quant data shows BIIB's Short term Debt at $800.0 million in Q2 2026, $150.0 million in Q2 2025, and $1.7 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Biogen 32.04 Bn 30.76 Bn 1.96 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 800.00 Mn
Jun 30, 2025 150.00 Mn
Dec 31, 2024 1.75 Bn
Dec 31, 2023 150.00 Mn
Dec 31, 2021 999.10 Mn
Dec 31, 2019 1.50 Bn
Mar 31, 2018 3.30 Mn
Dec 31, 2017 3.20 Mn
Sep 30, 2017 573.20 Mn
Jun 30, 2017 559.90 Mn
Mar 31, 2017 561.50 Mn
Dec 31, 2016 4.70 Mn
Sep 30, 2016 4.90 Mn
Jun 30, 2016 4.80 Mn
Mar 31, 2016 4.90 Mn
Dec 31, 2015 4.80 Mn
Sep 30, 2015 5.17 Mn
Jun 30, 2015 3.26 Mn
Mar 31, 2015 3.25 Mn
Dec 31, 2014 3.10 Mn